- Home
- KRUS vs RLAY Comparison
KRUS vs RLAY Comparison
Compare KRUS & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRUS | RLAY |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 697.5M | 1.3B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KRUS | RLAY |
|---|---|---|
| Price | $64.11 | $9.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $81.50 | $16.86 |
| AVG Volume (30 Days) | 178.1K | ★ 2.4M |
| Earning Date | 04-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.75 | 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $282,763,000.00 | $15,355,000.00 |
| Revenue This Year | $21.66 | N/A |
| Revenue Next Year | $17.89 | $324.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 18.88 | ★ 53.44 |
| 52 Week Low | $40.07 | $1.78 |
| 52 Week High | $95.98 | $11.49 |
Technical Indicators
Market Signals| Indicator | KRUS | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 52.49 | 47.18 |
| Support Level | $61.69 | $9.06 |
| Resistance Level | $67.70 | $9.54 |
| Average True Range (ATR) | 3.60 | 0.62 |
| MACD | 0.29 | -0.13 |
| Stochastic Oscillator | 70.62 | 17.70 |
Price Performance
Historical ComparisonAbout KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled Japanese restaurant concept that provides guests with a distinctive dining experience by serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. The company operates a network of dine-in locations across the U.S. states and Washington, DC.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).